Print

American College of Gastroenterology: Acute IBD Flares Respond to Infliximab, University of Pittsburgh Study  
10/20/2010 7:11:41 AM

MedPageToday -- SAN ANTONIO -- Hospitalized patients with exacerbations of Crohn's disease or ulcerative colitis who are naive to anti-tumor necrosis factor agents did well when given infliximab (Remicade), researchers found.
//-->